CI
SGYP

Conning Inc’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Conning Inc’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-299,300
Closed -$1.65M – 601
2016
Q3 		$1.65M Buy
+299,300
New +$1.4M 0.07% 205

Other funds holding SGYP

PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Conning Inc's SGYP Position: Q4 2016 in Review

Conning Inc sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2016, closing a stake of 299,300 shares — an estimated $1.65M sold.

Conning Inc first reported a position in SGYP in Q3 2016 and held it in 1 quarter. The position peaked at $1.65M in Q3 2016. 156 funds tracked by Wall St. Rank hold SGYP as of Q4 2016.

  • Conning Inc reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2016 after selling out during the quarter.
  • Conning Inc sold 299,300 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2016, an estimated $1.65M.
  • Conning Inc first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q3 2016 and held it in 1 quarter.
  • Conning Inc's Synergy Pharmaceuticals, Inc Common Stock position peaked at $1.65M in Q3 2016.
  • 156 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2016.

Based on Conning Inc's 13F filing for Q4 2016, filed 2 Feb 2017.